These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 24893789)

  • 1. Diuretic ¹⁸F-FDG PET/CT for therapy monitoring in urothelial bladder cancer.
    Coquan E; Lasnon C; Joly F; Lefort JM; Aide N
    Eur J Nucl Med Mol Imaging; 2014 Sep; 41(9):1818-9. PubMed ID: 24893789
    [No Abstract]   [Full Text] [Related]  

  • 2. Three synchronous primary malignancies detected by F-18 FDG PET/CT: breast, rectal, and urothelial bladder carcinomas.
    Makis W; Ciarallo A; Lisbona R
    Clin Nucl Med; 2011 Sep; 36(9):791-4. PubMed ID: 21825852
    [No Abstract]   [Full Text] [Related]  

  • 3. Diuretic 18F-FDG PET/CT imaging for detection and locoregional staging of urinary bladder cancer: prospective evaluation of a novel technique.
    Nayak B; Dogra PN; Naswa N; Kumar R
    Eur J Nucl Med Mol Imaging; 2013 Feb; 40(3):386-93. PubMed ID: 23179944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preoperative lymph-node staging of invasive urothelial bladder cancer with 18F-fluorodeoxyglucose positron emission tomography/computed axial tomography and magnetic resonance imaging: correlation with histopathology.
    Jensen TK; Holt P; Gerke O; Riehmann M; Svolgaard B; Marcussen N; Bouchelouche K
    Scand J Urol Nephrol; 2011 Mar; 45(2):122-8. PubMed ID: 21231796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of (18) F-fluorodeoxyglucose (FDG)-positron-emission tomography/computed tomography (PET/CT) on management of patients with carcinoma invading bladder muscle.
    Mertens LS; Fioole-Bruining A; Vegt E; Vogel WV; van Rhijn BW; Horenblas S
    BJU Int; 2013 Oct; 112(6):729-34. PubMed ID: 23790129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diuretic 18F-Fluorodeoxyglucose PET/Computed Tomography in Evaluation of Genitourinary Malignancies.
    Agarwal KK; Roy SG; Kumar R
    PET Clin; 2016 Jan; 11(1):39-46. PubMed ID: 26590442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluorodeoxyglucose positron-emission tomography (FDG PET)/computed tomography (CT) in bladder cancer.
    Goh V; Cook G
    BJU Int; 2013 Oct; 112(6):709. PubMed ID: 24028759
    [No Abstract]   [Full Text] [Related]  

  • 8. Commentary on "Impact of (18) F-fluorodeoxyglucose (FDG)-positron-emission tomography/computed tomography (PET/CT) on management of patients with carcinoma invading bladder muscle." Mertens LS, Fioole-Bruining A, Vegt E, Vogel WV, van Rhijn BW, Horenblas S, Department of Urology, The Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam Hospital, Amsterdam, The Netherlands.: BJU Int 2013; 112(6):72934. doi:10.1111/bju.12109. [Epub 2013 Jun 24].
    See WA
    Urol Oncol; 2014 Nov; 32(8):1350. PubMed ID: 25488385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interesting image. Correlative imaging with FDG PET-CT and MRI of an unusual recurrence of urothelial cancer in an ileal conduit.
    Purandare NC; Dua S; Shah S; Gupta K; Sharma AR; Rangarajan V
    Clin Nucl Med; 2010 Jan; 35(1):42-3. PubMed ID: 20026976
    [No Abstract]   [Full Text] [Related]  

  • 10. Extraperitoneal urinary bladder perforation detected by FDG PET/CT.
    Wosnitzer B; Mirtcheva R
    J Radiol Case Rep; 2011; 5(4):32-40. PubMed ID: 22470789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduction of bladder activity on FDG PET/CT scan in patients with urinary bladder carcinoma. A prospective study with a patient-friendly protocol.
    Tsai SC; Ou YC; Cheng CL; Li JR; Lin YC; Ho HC; Chiu KY; Su CK; Lin WY
    Nuklearmedizin; 2015; 54(1):36-42. PubMed ID: 25345433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A rare case of large cell neuroendocrine carcinoma of the urinary bladder evaluated by ¹⁸F-FDG-PET/CT.
    Treglia G; Paone G; Flores B; Venzi G; Ceriani L; Giovanella L
    Rev Esp Med Nucl Imagen Mol; 2014; 33(5):312-3. PubMed ID: 24440201
    [No Abstract]   [Full Text] [Related]  

  • 13. Delayed diuretic FDG PET/CT scan facilitates detection of renal urothelial cell carcinoma.
    Yeh CL; Chen SW; Chen YK
    Clin Nucl Med; 2009 Nov; 34(11):829-30. PubMed ID: 19851191
    [No Abstract]   [Full Text] [Related]  

  • 14. Proposal of a new acquisition protocol for bladder cancer visualization with 18F-FDG PET/CT.
    Chondrogiannis S; Marzola MC; Colletti PM; Rubello D
    Clin Nucl Med; 2015 Jan; 40(1):e78-80. PubMed ID: 24566416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Feasible method to successfully uncover a urothelial carcinoma in the urinary bladder on the FDG PET/CT scan masked by physiological urine radioactivity.
    Shen YY; Kao CH; Yeh LH; Juang GD; Liang JA; Hsieh TC
    Clin Nucl Med; 2010 Jun; 35(6):464-6. PubMed ID: 20479605
    [No Abstract]   [Full Text] [Related]  

  • 16. 18F-FDG PET/CT delayed images after diuretic for restaging invasive bladder cancer.
    Anjos DA; Etchebehere EC; Ramos CD; Santos AO; Albertotti C; Camargo EE
    J Nucl Med; 2007 May; 48(5):764-70. PubMed ID: 17475965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [(18)F]Fluorodeoxyglucose - positron emission tomography/computed tomography improves staging in patients with high-risk muscle-invasive bladder cancer scheduled for radical cystectomy.
    Kollberg P; Almquist H; Bläckberg M; Cronberg C; Garpered S; Gudjonsson S; Kleist J; Lyttkens K; Patschan O; Liedberg F
    Scand J Urol; 2015; 49(4):296-301. PubMed ID: 25623843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delayed imaging of the pelvis with diluted and filled bladder: a simple and efficient method in FDG PET/CT imaging of bladder carcinoma.
    Halac M; Aliyev A; Yılmaz S; Ozhan M; Kaya R; Sağer S; Ergül N
    Clin Nucl Med; 2012 Aug; 37(8):778-80. PubMed ID: 22785509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison between the diagnostic accuracies of 18F-fluorodeoxyglucose positron emission tomography/computed tomography and conventional imaging in recurrent urothelial carcinomas: a retrospective, multicenter study.
    Zattoni F; Incerti E; Colicchia M; Castellucci P; Panareo S; Picchio M; Fallanca F; Briganti A; Moschini M; Gallina A; Karnes JR; Lowe V; Fanti S; Schiavina R; Rambaldi I; Ficarra V; Evangelista L
    Abdom Radiol (NY); 2018 Sep; 43(9):2391-2399. PubMed ID: 29302738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FDG-PET/CT for the preoperative lymph node staging of invasive bladder cancer.
    Swinnen G; Maes A; Pottel H; Vanneste A; Billiet I; Lesage K; Werbrouck P
    Eur Urol; 2010 Apr; 57(4):641-7. PubMed ID: 19477579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.